Progress and Promise of Biomarker Discovery and Development in Urologic Disease

Over the past several years, there has been an enormous amount of research in biomarkers in both benign and malignant urologic conditions. Scientific advances using a multitude of various -omics pathways, including genomics, transcriptomics, proteomics, metabolomics, radiomics, microbiomics, and other methods using olfaction-based research have afforded investigators with multiple new tools to interrogate blood, urine, seminal fluid, and tissue for promising novel biomarkers. Furthermore, the efficiency and cost associated with these analyses have dramatically improved, resulting in an ability to perform larger-scale investigations in a high-throughput manner.
Source: Urologic Clinics of North America - Category: Urology & Nephrology Authors: Tags: Preface Source Type: research